请输入您要查询的百科知识:

 

词条 Leibniz-Forschungsinstitut für Molekulare Pharmakologie
释义

  1. Research Areas

  2. Collaborations

  3. Funding

  4. History

  5. Directors of the FMP

  6. References

{{Infobox institute
| name = Leibniz-Forschungsinstitut für Molekulare Pharmakologie
| image = Logo of Leibniz-FMP from 2017.svg
| image_size = 320
| image_upright =
| alt =
| caption =
| latin_name =
| motto =
| founder =
| established = 1992
| mission =
| focus = cell biology, chemical biology, neurobiology, structural biology
| head_label = Director(s)
| head = Dorothea Fiedler, Volker Haucke
| faculty =
| adjunct_faculty =
| staff =
| key_people =
| budget = 21 million euros (2012)
| num_members = 270
| former_name = Institut für Wirkstofforschung, Leibniz-Institut für Molekulare Pharmakologie
| location =
| city = Berlin
| state = Berlin
| country = Germany
| coor = {{nowrap|{{coord|52.624337|N|13.504139|E|region:DE-BE_type:landmark_source:wikidata|display=inline}}}}
| address = Campus Buch, Robert-Roessle-Str. 10, Berlin 13125
| website = {{URL|https://www.leibniz-fmp.de/}}
| dissolved =
| footnotes =
}}

The Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is a research institute in the Leibniz Association, focussing on proteins as basic structures of cellular organisms. It is one of the large number of research institutions based in Berlin. The institute is situated on a research campus in Buch, a northern district of Berlin. Legally, the FMP and seven other Leibniz Institutes based in Berlin are represented by the Forschungsverbund Berlin (Research Association of Berlin).

The institute has around 270 employees[1], including researchers and administrative staff.



Research Areas

The Institute focuses on fundamental research in life sciences, with a interdisciplinary approach based on chemistry and biology. The institute is organized into three departments under the broad umbrella of molecular pharmacology:[2]

  • Molecular physiology and cell biology
  • Structural biology
  • Chemical biology

Collaborations

The institute has many collaborations with national and international universities and research institutes, as well as businesses. Collaboration partners include:

  • Free University, Berlin, Germany[3][4]
  • Max Delbrück Center for Molecular Medicine, Berlin, Germany[5][6]
  • European Molecular Biology Laboratory, Heidelberg, Germany[7]
  • Hannover Medical School, Hannover, Germany[8]
  • University of Potsdam, Potsdam, Germany[8]
  • Hospital for Sick Children, Canada[8]
  • Université Paris Diderot, France[8]
  • INSERM, France[8]
  • University of Melbourne, Australia[9][10]
  • University of Geneva, Switzerland[11]
  • Schering AG[12]

Funding

The Institute receives core and external funding. The core funding (Grundfinanzierung) is usually split equally between federal and state contributions.[13] In 2012, the institute had a total revenue of 21 million euros, excluding DFG fees.[14]

History

The institute was founded in 1992 as a successor to the "Institut für Wirkstofforschung" (Institute for Active Materials Research, also translated as the Drugs Research Institute), an Institute of the Academy of Sciences of the GDR. The Institut für Wirkstofforschung was founded in 1977 by Peter Oehme, who also served as its first and only director, and had around 230 employees.[15] After the reunification of Germany, scientific institutions underwent a period of readjustment to align those in the former east and west.[16] In 1991, the German Council of Science and Humanities (Wissenschaftsrat) recommended the founding of an institute focused in the area of molecular pharmacology,[15] which led to the establishment of the institute as it is known today.

The institute was originally located in Friedrichsfelde in east Berlin, but moved to its current location in Buch in 2000.

Since the founding of the institute, it has been a member of the Leibniz Association. The Institute does not have an official English name, and the acronym "FMP" was used heavily. From 2006, the institute was named Leibniz-Institut für Molekulare Pharmakologie (Leibniz Institute for Molecular Pharmacology), though the institute logo still contained the "FMP" acronym. In May 2017, it was renamed back to "Leibniz-Forschungsinstitut für Molekulare Pharmakologie" (Leibniz Research Institute for Molecular Pharmacology).

Directors of the FMP

  • 1996-2008: Walter Rosenthal
  • 2009-2011: Hartmut Oschkinat (acting director)[17]
  • 2012-present: Volker Haucke
  • 2015-present: Dorothea Fiedler

References

1. ^{{Cite web|url=https://www.leibniz-fmp.de/institute/about-us.html|title=FMP Berlin: About us|website=www.leibniz-fmp.de|access-date=2019-03-17}}
2. ^{{Cite web|url=https://www.leibniz-fmp.de/research/research.html|title=FMP Berlin: Research Areas|last=|first=|date=|website=www.leibniz-fmp.de|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
3. ^{{Cite web|url=https://www.leibniz-fmp.de/press-media/research-highlights/press-releases-single-view11/article/presynapses-come-in-a-packet-berlin-scientists-identify-the-components-and-architecture-of-neuro-1.html|title=FMP Berlin: Presynapses come in a packet – Berlin Scientists Identify the Components and Architecture of Neuronal Contact Sites|last=|first=|date=2018-08-31|website=www.leibniz-fmp.de|publisher=FMP Berlin|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
4. ^{{Cite web|url=https://www.leibniz-fmp.de/press-media/press-releases/press-releases-single-view1/article/ein-protein-fuers-lernen.html|title=FMP Berlin: A protein for learning|date=2019-03-04|website=www.leibniz-fmp.de|publisher=FMP Berlin|language=en|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
5. ^{{Cite web|url=https://www.leibniz-fmp.de/press-media/research-highlights/press-releases-single-view11/article/when-bacteria-build-homes-1.html|title=FMP Berlin: When Bacteria Build Homes|last=|first=|date=2018-05-04|website=www.leibniz-fmp.de|publisher=FMP Berlin|language=en|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
6. ^{{Cite web|url=https://www.leibniz-fmp.de/press-media/research-highlights/press-releases-single-view11/article/how-a-mutated-gene-triggers-hypertension.html|title=FMP Berlin: How a Mutated Gene Triggers Hypertension|date=2018-04-04|website=www.leibniz-fmp.de|publisher=FMP Berlin|language=en|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
7. ^{{Cite journal|last=Due|first=Anne V.|last2=Kuper|first2=Jochen|last3=Geerlof|first3=Arie|last4=Kries|first4=Jens Peter von|last5=Wilmanns|first5=Matthias|date=2011-03-01|title=Bisubstrate specificity in histidine/tryptophan biosynthesis isomerase from Mycobacterium tuberculosis by active site metamorphosis|url=http://www.pnas.org/lookup/doi/10.1073/pnas.1015996108|journal=Proceedings of the National Academy of Sciences|language=en|volume=108|issue=9|pages=3554–3559|doi=10.1073/pnas.1015996108|issn=0027-8424|pmc=3048130|pmid=21321225}}
8. ^{{Cite journal|last=Otten|first=Cécile|last2=Knox|first2=Jessica|last3=Boulday|first3=Gwénola|last4=Eymery|first4=Mathias|last5=Haniszewski|first5=Marta|last6=Neuenschwander|first6=Martin|last7=Radetzki|first7=Silke|last8=Vogt|first8=Ingo|last9=Hähn|first9=Kristina|date=2018-09-04|title=Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations|url=https://www.ncbi.nlm.nih.gov/pubmed/30181117|journal=EMBO molecular medicine|volume=10|issue=10|pages=|doi=10.15252/emmm.201809155|issn=1757-4684|pmc=6180302|pmid=30181117|via=}}
9. ^{{Cite journal|last=Kesten|first=Christopher|last2=Wallmann|first2=Arndt|last3=Schneider|first3=René|last4=McFarlane|first4=Heather E.|last5=Diehl|first5=Anne|last6=Khan|first6=Ghazanfar Abbas|last7=van Rossum|first7=Barth-Jan|last8=Lampugnani|first8=Edwin R.|last9=Szymanski|first9=Witold G.|date=2019-02-20|title=The companion of cellulose synthase 1 confers salt tolerance through a Tau-like mechanism in plants|url=http://www.nature.com/articles/s41467-019-08780-3|journal=Nature Communications|language=en|volume=10|issue=1|pages=|doi=10.1038/s41467-019-08780-3|issn=2041-1723|pmc=6382854|pmid=30787279|via=}}
10. ^{{Cite web|url=https://www.leibniz-fmp.de/press-media/press-releases/press-releases-single-view1/article/salzprinz-cc1-neu-entdecktes-protein-hat-wichtige-funktion-in-pflanzen-und-koennte-auch-f.html|title=FMP Berlin: "Salt Prince" CC1: Newly discovered protein has important function in plants - and could also be important for Alzheimer's research|date=2019-02-18|website=www.leibniz-fmp.de|publisher=FMP Berlin|language=en|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
11. ^{{Cite journal|last=Wang|first=Haibin|last2=Lo|first2=Wen-Ting|last3=Vujičić Žagar|first3=Andreja|last4=Gulluni|first4=Federico|last5=Lehmann|first5=Martin|last6=Scapozza|first6=Leonardo|last7=Haucke|first7=Volker|last8=Vadas|first8=Oscar|date=2018-07-19|title=Autoregulation of Class II Alpha PI3K Activity by Its Lipid-Binding PX-C2 Domain Module|url=https://linkinghub.elsevier.com/retrieve/pii/S1097276518305458|journal=Molecular Cell|language=en|volume=71|issue=2|pages=343–351.e4|doi=10.1016/j.molcel.2018.06.042|via=}}
12. ^{{Cite web|url=https://www.leibniz-fmp.de/research/structuralbiology/researchgroups/kuehne/cooperationpartnersmolecularmod.html|title=FMP Berlin: Cooperations (Kuehne group)|last=|first=|date=|website=www.leibniz-fmp.de|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
13. ^{{Cite web|url=http://www.bundesbericht-forschung-und-innovation.de/de/Grundfinanzierung-der-Forschungseinrichtungen-1789.html|title=Grundfinanzierung der Forschungseinrichtungen - BuFI Kampagne|last=Projektträger|first=Redaktion: DLR|website=Bundesbericht Forschung und Innovation - BuFI Kampagne|language=de|access-date=2019-03-17}}
14. ^{{cite report|url=https://www.leibniz-gemeinschaft.de/fileadmin/user_upload/downloads/Evaluierung/Senatsstellungnahmen/FMP_-_Senatsstellungnahme_27-11-2014_mit_Anlagen.pdf|title=Stellungnahme zum Leibniz-Institut für Molekulare Pharmakologie (FMP) im Forschungsverbund Berlin e. V|author=|authors=|first=|date=2014-11-27|publisher=Evaluation Committee of the Leibniz Association|issue=|doi=|volume=|page=|language=de, en|pmid=|docket=|quote=|author-link=|access-date=2019-03-17}}
15. ^{{cite report|url=https://www.wissenschaftsrat.de/download/archiv/0335-91_IWF.pdf|title=Stellungnahmen zu den außeruniversitären Forschungseinrichtungen in der ehemaligen DDR auf dem Gebiet der Biowissenschaften und der Medizin {{!}} Institut für Wirkstofforschung (IWF), Berlin|last=|first=|date=Jul 1991|publisher=Wissenschaftsrat|issue=|doi=|volume=335/91|page=|pages=41-49|language=de|pmid=|quote=|author-link=|access-date=2019-03-17|format=PDF|section=}}
16. ^{{Cite web|url=https://www.dw.com/en/east-german-scientists-faced-opportunities-and-disappointment-during-reunification/a-6051868|title=East German scientists faced opportunities and disappointment during reunification {{!}} DW {{!}} 28.09.2010|last=|first=|date=|website=www.dw.com|publisher=Deutsche Welle|language=en-GB|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
17. ^{{Cite web|url=https://www.leibniz-fmp.de/de/research/structuralbiology/researchgroups/oschkinat/curriculumvitae.html|title=FMP Berlin: Hartmut Oschkinat - Curriculum Vitae|last=|first=|date=|website=www.leibniz-fmp.de|archive-url=|archive-date=|dead-url=|access-date=2019-03-17}}
{{commons category|Leibniz-Forschungsinstitut für Molekulare Pharmakologie}}{{coord|52.624337|N|13.504139|E|region:DE-BE_type:landmark_source:wikidata|display=title}}{{Authority control}}{{DEFAULTSORT:Leibniz-Institut fur Molekulare Pharmakologie}}{{edu-org-stub}}{{Germany-university-stub}}

4 : Leibniz Association|Buildings and structures in Berlin|Molecular biology institutes|Research institutes established in 1992

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/24 0:20:55